CELLERIX, S.L.;CENTRO SUPERIOR DE INVESTIGACIONES CIENTIFICAS;CELLERIX; S.L.
发明人:
BUESCHER, DIRK,GONZALEZ DE LA PENA, MANUEL ANGEL,DELGADO MORA, MARIO
申请号：
CA2623353
公开号：
CA2623353C
申请日:
2006.09.22
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The present invention provides a population of connective tissue derived cellsthat respond to interferon-gamma (IFN-.gamma.) by expressing indolamine-2,3-dioxygenase (IDO) for use in preventing, treating or ameliorating one or moresymptoms associated with disorders in which modulation of a subject's immunesystem is beneficial, including, but not limited to, autoimmune diseases,inflammatory disorders, and immunologically mediated diseases includingrejection of transplanted organs and tissues.
